Search research articles
Contact Us
Filters
Showing results (591-600 of 942) with videos related to
Page
of 95
Sort By:
Clinical Chemistry
|
November 19, 2011
Role of ST2 in non-ST-elevation acute coronary syndrome in the MERLIN-TIMI 36 trial
Payal Kohli, Marc P Bonaca, Rahul Kakkar, et al.
Journal of Viral Hepatitis
|
September 15, 2011
HBV lamivudine resistance among hepatitis B and HIV coinfected patients starting lamivudine, stavudine and nevirapine in Kenya
H N Kim, J Scott, A Cent, et al.
Circulation
|
December 28, 2018
Performance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients With Atrial Fibrillation in ENGAGE AF-TIMI 48
David D Berg, Christian T Ruff, Petr Jarolim, et al.
Diabetes Care
|
December 3, 2017
Risk Assessment in Patients With Diabetes With the TIMI Risk Score for Atherothrombotic Disease
Brian A Bergmark, Deepak L Bhatt, Eugene Braunwald, et al.
JACC. Heart Failure
|
September 13, 2020
Angiotensin-Neprilysin Inhibition in Black Americans: Data From the PIONEER-HF Trial
Cecilia Berardi, Eugene Braunwald, David A Morrow, et al.
JAMA Cardiology
|
October 19, 2022
Association of Serial High-Sensitivity Cardiac Troponin T With Subsequent Cardiovascular Events in Patients Stabilized After Acute Coronary Syndrome: A Secondary Analysis From IMPROVE-IT
Siddharth M Patel, Arman Qamar, Robert P Giugliano, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
January 18, 2018
Kidney Biomarkers and Decline in eGFR in Patients with Type 2 Diabetes
Katherine G Garlo, William B White, George L Bakris, et al.
European Heart Journal
|
March 15, 2008
Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18
David A Morrow, Marc S Sabatine, Marie-Luise Brennan, et al.
International Journal of Cardiology
|
May 21, 2023
Neutrophil-lymphocyte ratio and clinical outcomes in 19,697 patients with atrial fibrillation: Analyses from ENGAGE AF- TIMI 48 trial
Antonio Fagundes, Christian T Ruff, David A Morrow, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
June 9, 2025
First-Line Use of Higher-Efficacy Disease-Modifying Therapies in Multiple Sclerosis: Canadian Consensus Recommendations
Mark S Freedman, Fraser Clift, Virginia Devonshire, et al.
Page
of 95
Search research articles
Search
Showing results (591-600 of 942) with videos related to
Sort By:
Page
of 95
Clinical Chemistry
|
November 19, 2011
Role of ST2 in non-ST-elevation acute coronary syndrome in the MERLIN-TIMI 36 trial
Payal Kohli, Marc P Bonaca, Rahul Kakkar, et al.
Journal of Viral Hepatitis
|
September 15, 2011
HBV lamivudine resistance among hepatitis B and HIV coinfected patients starting lamivudine, stavudine and nevirapine in Kenya
H N Kim, J Scott, A Cent, et al.
Circulation
|
December 28, 2018
Performance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients With Atrial Fibrillation in ENGAGE AF-TIMI 48
David D Berg, Christian T Ruff, Petr Jarolim, et al.
Diabetes Care
|
December 3, 2017
Risk Assessment in Patients With Diabetes With the TIMI Risk Score for Atherothrombotic Disease
Brian A Bergmark, Deepak L Bhatt, Eugene Braunwald, et al.
JACC. Heart Failure
|
September 13, 2020
Angiotensin-Neprilysin Inhibition in Black Americans: Data From the PIONEER-HF Trial
Cecilia Berardi, Eugene Braunwald, David A Morrow, et al.
JAMA Cardiology
|
October 19, 2022
Association of Serial High-Sensitivity Cardiac Troponin T With Subsequent Cardiovascular Events in Patients Stabilized After Acute Coronary Syndrome: A Secondary Analysis From IMPROVE-IT
Siddharth M Patel, Arman Qamar, Robert P Giugliano, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
January 18, 2018
Kidney Biomarkers and Decline in eGFR in Patients with Type 2 Diabetes
Katherine G Garlo, William B White, George L Bakris, et al.
European Heart Journal
|
March 15, 2008
Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18
David A Morrow, Marc S Sabatine, Marie-Luise Brennan, et al.
International Journal of Cardiology
|
May 21, 2023
Neutrophil-lymphocyte ratio and clinical outcomes in 19,697 patients with atrial fibrillation: Analyses from ENGAGE AF- TIMI 48 trial
Antonio Fagundes, Christian T Ruff, David A Morrow, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
June 9, 2025
First-Line Use of Higher-Efficacy Disease-Modifying Therapies in Multiple Sclerosis: Canadian Consensus Recommendations
Mark S Freedman, Fraser Clift, Virginia Devonshire, et al.
Page
of 95